NSTG - ナノストリング・テクノロジ―ズ (NanoString Technologies Inc.) ナノストリング・テクノロジ―ズ

 NSTGのチャート


 NSTGの企業情報

symbol NSTG
会社名 NanoString Technologies Inc (ナノストリング・テクノロジ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ナノストリング・テクノロジーズ(NanoString Technologies Inc.)は微量の組織から実用的なゲノム情報を科学的・臨床的に解き明かす製品の設計・製作・販売に従事する。同社は、単一の組織サンプルから数百の遺伝子およびタンパク質の活性を同時にプロファイリングするための機器、消耗品およびサービスの開発、製造および販売に従事する。同社のnCounter Analysis Systemはバーコード技術を使用して数百分子の分子を直接プロファイリングする自動化されたマルチアプリケーション、デジタル検出およびカウントシステムである。同社は基本的な生物学およびがんのような疾患の分子基盤、および診断用の臨床検査機関および医療センターに使用するためにシステムおよび関連消耗品を学術、政府および生物医薬品研究所の研究者に販売する。   ナノストリング・テクノロジ―ズは、米国の医療機器メ―カ―。ダイレクトデジタル計測遺伝子解析システム「nCounter」を開発、製造、販売する。バ―コ―ド技術により、最大800遺伝子を1チュ―ブで同時カウントする「nCounter」と関連する消耗品を学術、政府の研究者や臨床検査室、医療センタ―へ販売する。   NanoString Technologies, Inc. engages in the development and commercialization of instrument and services for profiling of genes and proteins from tissue sample. It offers GeoMx Digital Spatial Profiler, nCounter Systems, analysis solutions, gene expression panels, Vantage 3D Assays, miRNA Assays, custom solutions, and Sample Prep and nCounter Consumables. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.
本社所在地 530 Fairview Avenue North Seattle WA 98109 USA
代表者氏名 William D. Young ウィリアム・D・ヤング
代表者役職名 Independent Chairman of the Board
電話番号 +1 206-378-6266
設立年月日 37773
市場名 NASDAQ National Market System
ipoyear 2013年
従業員数 467人
url www.nanostring.com
nasdaq_url https://www.nasdaq.com/symbol/nstg
adr_tso
EBITDA EBITDA(百万ドル) -50.37300
終値(lastsale) 15.61
時価総額(marketcap) 464987745.32
時価総額 時価総額(百万ドル) 471.83890
売上高 売上高(百万ドル) 110.33300
企業価値(EV) 企業価値(EV)(百万ドル) 470.87190
当期純利益 当期純利益(百万ドル) -22.26800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NanoString Technologies Inc revenues decreased 9% to $48.1M. Net loss increased 70% to $39.8M. Revenues reflect North America segment decrease of 17% to $32.8M Asia Pacific segment decrease of 10% to $3.1M. Higher net loss reflects Research and development increase of 30% to $28.4M (expense) Selling general and administrative increase of 11% to $40.1M (expense).

 NSTGのテクニカル分析


 NSTGのニュース

   NanoString and Oregon Health & Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer  2020/11/17 11:00:00 Business Wire
NanoString and OHSU Announce Collaboration to Develop GeoMx Assays for Breast Cancer
   NanoString to Present at the Stifel 2020 Virtual Healthcare Conference  2020/11/12 21:01:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString to present at the 2020 Stifel Healthcare Conference.
   NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)  2020/11/11 11:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString announces research highlights from SITC 2020.
   Global Microscopy-based RNA Imaging Techniques Market 2020-2026 will change the Future | Major Giants –Nikon Instruments Inc., NanoString Technologies, Inc., 10x Genomics, CARTANA AB  2020/11/10 05:46:35 OpenPR
Data Bridge Market Research has recently added a concise research on the Global Microscopy-based RNA Imaging Techniques Market to depict valuable insights related to significant market trends driving the industry. Global Microscopy-based RNA Imaging Techniques Market research report has been produced with
   NanoString Technologies Releases Operating Results for Third Quarter of 2020  2020/11/09 21:01:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString reports Q3 operating results.
   NanoString Technologies Releases Operating Results for Second Quarter of 2020  2020/08/10 20:01:00 Business Wire
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies Releases Operating Results for Second Quarter of 2020
   NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler  2020/08/06 10:00:00 Business Wire
SEATTLE & MINNEAPOLIS--(BUSINESS WIRE)--NanoString Expands RNAscope Partnership with Bio-Techne's ACD Division.
   NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers  2020/08/03 10:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)-- #GeoMxDSP--NanoString announces next generation sequencing read-out for the GeoMx Digital Spatial Profiler.
   NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020  2020/07/08 10:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Announces Second Quarter Conference Call
   Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research  2020/05/12 10:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString Highlights Recent Publications that Demonstrate the Performance of the GeoMx DSP.
   Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research  2020/05/12 10:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString Highlights Recent Publications that Demonstrate the Performance of the GeoMx DSP.
   NanoString Technologies Releases Operating Results for First Quarter of 2020  2020/05/07 20:01:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString reports first quarter 2020 operating results.
   NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes  2020/03/05 11:00:00 Business Wire
SEATTLE, Wash.--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625% convertible senior notes due 2025 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). NanoString also granted the initial purchasers of the notes a 13-day option to purchase u
   Will NanoString Technologies Continue to Surge Higher?  2020/03/02 11:05:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in NanoString Technologies.
   Veracyte registers 376,732 of holder NanoString's shares for resale  2020/02/26 00:04:24 Seeking Alpha
Veracyte (NASDAQ:VCYT) has filed a prospectus supplement to register for resale up to 376,732 shares issued to NanoString Technologies. Those shares were i

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ナノストリング・テクノロジ―ズ NSTG NanoString Technologies Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)